Case Study: Penn Medicine reduces post-ACS hospital readmissions with Wellth

Randomized Controlled Trial shows Wellth reduces hospital readmissions post-ACS by 45%

Penn Medicine faced the challenge of improving medication adherence for acute coronary syndrome (ACS) patients post-discharge, as nonadherence to aspirin regimens was a significant contributor to costly cardiovascular readmissions and death. To address this, they partnered with Wellth to implement a behavioral economics-based program.

Wellth provided an app-based solution that used daily financial incentives, reminders, and photo verification to motivate patients to take their medication. The results from the randomized controlled trial showed a median 90-day adherence rate of 98% and a 45% reduction in 90-day hospital readmissions for the intervention group compared to the control. This outcome demonstrated Wellth's substantial impact on both patient behavior and clinical outcomes.

Penn Medicine